PinCell is formerly owned by Sofinnova Partners, through Sofinnova Capital IX, since 2019.

When did Sofinnova Partners acquire PinCell?

Sofinnova Partners acquired PinCell in 2019 and exited after 6 years.

Has PinCell been sold?

Yes. PinCell was exited in 2025 via Trade Sale.

Home/Companies/Biotech/PinCell

PinCell

Biotech·

Italy·Exited 2025·Held 6yr

PinCell is a healthcare / biotech company, headquartered in Italy.

Entry

2019

Hold

6yr

Exit

2025

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQItaly

SectorHealthcare / Biotech

Cell therapy biotech. Exit circa 2023 | Acquired by Scinai Immunotherapeutics on March 27, 2025. DB had exit_year=2023, corrected to 2025.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from Sofinnova Capital IX

Other portfolio companies in the same fund.

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings